Theriva Biologics (TOVX) Minority Interest (2015 - 2021)
Theriva Biologics (TOVX) posted quarterly Minority Interest of -$2.8 million for Q3 2021, down 0.87% year-over-year from -$2.8 million in Q3 2020, and little changed quarter-over-quarter from -$2.8 million in Q2 2021.
Theriva Biologics (TOVX) Minority Interest (2015 - 2021) Analysis & Trends
Theriva Biologics (TOVX) has reported Minority Interest for 7 consecutive years, with -$2.8 million the latest figure, recorded in Q3 2021.
- In Q3 2021, Minority Interest fell 0.87% year-over-year to -$2.8 million; the TTM figure through Sep 2021 stood at -$2.8 million (down 0.87% YoY), while the FY2020 annual figure was -$2.8 million, up 3.65% from the prior year.
- Minority Interest was little changed at -$2.8 million in Q3 2021 per TOVX's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Minority Interest topped out at -$1.8 million in Q1 2017 and bottomed at -$2.9 million in Q4 2018.
- Historically, Minority Interest has averaged -$2.5 million across 5 years, with a median of -$2.8 million in 2021.
- Annual changes were most pronounced in 2018 — Minority Interest plunged 51.99% — and 2021, when it gained 3.81%.
- Theriva Biologics' Minority Interest stood at -$1.9 million in 2017, then tumbled by 51.99% to -$2.9 million in 2018, then grew by 1.07% to -$2.9 million in 2019, then rose by 3.65% to -$2.8 million in 2020, then dropped by 0.04% to -$2.8 million in 2021.
- Business Quant data shows TOVX's Minority Interest at -$2.8 million in Q3 2021, -$2.8 million in Q2 2021, and -$2.8 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.77 Mn |
| Jun 30, 2021 | -2.77 Mn |
| Mar 31, 2021 | -2.77 Mn |
| Dec 31, 2020 | -2.77 Mn |
| Sep 30, 2020 | -2.75 Mn |
| Jun 30, 2020 | -2.88 Mn |
| Mar 31, 2020 | -2.88 Mn |
| Dec 31, 2019 | -2.88 Mn |
| Sep 30, 2019 | -2.84 Mn |
| Jun 30, 2019 | -2.85 Mn |
| Mar 31, 2019 | -2.87 Mn |
| Dec 31, 2018 | -2.91 Mn |
| Sep 30, 2018 | -1.95 Mn |
| Jun 30, 2018 | -1.94 Mn |
| Mar 31, 2018 | -1.92 Mn |
| Dec 31, 2017 | -1.91 Mn |
| Sep 30, 2017 | -1.88 Mn |
| Jun 30, 2017 | -1.87 Mn |
| Mar 31, 2017 | -1.81 Mn |
| Dec 31, 2016 | -1.60 Mn |